Stock & Company Details
Aquestive Therapeutics Inc $AQST
Price:
N/A
N/A
126M
$531M
52 Week High:
N/A
10 Day Average Volume:
N/A
-6.70
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
AQST technical indicators
Latest Aquestive Therapeutics Inc (AQST) indicator readings as of 2026-10-29.
AQST's 14-day RSI is 41.0, in neutral territory. At $4.04 it is trading 4.0% below its 200-day moving average of $4.21, and below its 50-day average of $4.67. Price sits in the middle of its Bollinger Bands ($3.64 to $4.99). ADX reads 19.1, indicating a range-bound market rather than a trend.
Overview
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.
Finance Bot
Ask your questions
Start by typing a question below.
